The warnings are divided into different levels, depending on the hazardousness of the substance. The distinction between the different levels is listed below.

Information

  • Samples with an unexpected ingredient that has a low risk potential (e.g. caffeine) or no psychoactive effect at all.
  • Samples containing synthesis by-products from which no toxic effects are known, but which indicate unprofessional production and whose risks cannot be conclusively assessed.

Caution

  • Samples with high dosage (ecstasy: more than 120 mg MDMA; felts: more than 150 μg LSD )
  • Samples that contain other psychoactive substances instead of or in addition to the expected substance and thus produce unexpected effects for the user.
  • Samples containing two psychoactive substances whose mixture poses a risk of undesirable side effects but is not acutely harmful to health.

Alerts

  • Samples with extremely high dosage (ecstasy: more than 200 mg MDMA; felts: more than 250 μg LSD ).
  • Samples with unexpected ingredients whose onset of action is later compared to the expected substance and which therefore pose a risk for overdoses
  • Samples containing other psychoactive substances instead of or in addition to the expected substance, the consumption of which poses an acute health risk or is potentially life-threatening.
  • Samples containing two or more psychoactive substances, the mixture of which poses a high health risk or entails effects that cannot be assessed.
  • Samples containing new psychoactive substances whose effects are not yet sufficiently known but are suspected to pose a high risk.